SYSTEMIC ADMINISTRATION OF RADIONUCLIDES IN NEURO-BLASTOMA AS PLANNED RADIOTHERAPEUTIC INTERVENTION

被引：7

作者：

LASHFORD, LS ^{[1
]}

CLARKE, J ^{[1
]}

KEMSHEAD, JT ^{[1
]}

机构：

[1] HOSP SICK CHILDREN,LONDON WC1N 3JH,ENGLAND

来源：

MEDICAL AND PEDIATRIC ONCOLOGY | 1990年 / 18卷 / 01期

关键词：

iodine; mIBG; monoclonal antibody; neuroblastoma; targeted radiotherapy;

D O I：

10.1002/mpo.2950180107

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Targeted radiotherapy, using systemically administered radionuclides, is an exciting proposition for the treatment of disseminated disease. In neuroblastoma, two groups of compounds have been developed as radiation delivery systems: monoclonal antibodies, exemplified by UJ13A, and the small‐molecular‐weight radio‐pharmaceutical meta‐Iodobenzylguanidene (mIBG). Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company

引用

页码：30 / 36

页数：7